Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

The European Commission approves AbbVie’s Skyrizi for pediatric patients with moderate to severe plaque psoriasis

23/06/2026 Published by Pharma Biz

Biopharmaceutical leader AbbVie has announced that the European Commission (EC) has formally granted marketing authorization expanding the indication for its... Read more

Tags: #Global Trends

US FDA declines to approve Achieve Life Sciences’ smoking-cessation drug over third-party manufacturing deficits

23/06/2026 Published by Pharma Biz

The U.S. Food and Drug Administration (FDA) has declined to approve Achieve Life Sciences' experimental drug engineered to treat adult... Read more

Category: Uncategorized

Tags: #Global Trends

Pfizer’s experimental antibody-drug conjugate misses primary endpoint in late-stage lung cancer trial

23/06/2026 Published by Pharma Biz

Global pharmaceutical giant Pfizer Inc. announced that a key experimental oncology drug acquired through its high-premium $43,000 million buyout of... Read more

Category: Uncategorized

Tags: #Global Trends

Shopify set to ban all vape products from its e-commerce platform under intense U.S. regulatory pressure

23/06/2026 Published by Pharma Biz

Ottawa-based e-commerce infrastructure giant Shopify Inc. is poised to ban all vaporizers and e-cigarettes (vapes) from its web hosting and... Read more

Category: Uncategorized

Tags: #Global Trends

Global oncological milestone: China approves world’s first solid tumor-targeted CAR-T cell therapy

23/06/2026 Published by Pharma Biz

China’s National Medical Products Administration (NMPA) has executed a series of historic regulatory clearances, spearheaded by the landmark global approval... Read more

Category: Uncategorized

Tags: #Global Trends

Nghe An Department of Health announces the executive appointment of Director of the Rehabilitation Hospital

23/06/2026 Published by Pharma Biz

On June 22, 2026, the Nghe An Department of Health organized an official ceremony to announce and deploy the executive... Read more

Category: Uncategorized

Tags: #Vietnam

SK pharmteco partners with OTXL to accelerate clinical timelines for rare disease therapeutics

22/06/2026 Published by Pharma Biz

Global CDMO giant SK pharmteco has finalized a definitive collaborative agreement with the Orphan Therapeutics Accelerator (OTXL)—a non-profit biotechnology organization... Read more

Category: Uncategorized

Tags: #Global Trends

Neurizon and Elanco ink long-term supply agreement for human-grade Monepantel to anchor ALS clinical pipeline

22/06/2026 Published by Pharma Biz

Biopharmaceutical innovator Neurizon Therapeutics has formalized a strategic, long-term supply agreement with Elanco Animal Health to secure comprehensive access to... Read more

Category: Uncategorized

Tags: #Global Trends